Updated on 6 August 2026
Flywheel Resources - A Canadian oil and gas investment opportunity
Managing Partner at PristineView Capital Advisers
China (Hong Kong)
About
Flywheel Resources Corp. is a discipline-driven private upstream oil & gas company in Canada, established in 2021. The company focuses on low-risk, high-return development opportunities in Alberta's southern Clearwater trend - executing a repeatable, engineering-driven model designed to support scalable production growth and efficient well-level economics.
The investment opportunity provides access to a cash-flow energy platform at a cyclical entry point, with visible production growth and exit optionality. With a proven asset base, experienced team, and replicable drilling program already underway, this offering represents a disciplined opportunity to participate in the revaluation of Canadian energy assets.
Project Location
- Canada
Project Website
https://www.flywheelresources.ca/
Project Format
- Private Project
Go Global Project
- Yes
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Investment / Financing Discussion
Main Project Sector
- Energy and Natural Resources
Energy and Natural Resources
- Oil & Gas
Total Project Value
- 50,000,001 USD or above
Investment Capital Required
- 25,000,001 to 50,000,000 USD
Interested Format of Cooperation
- Direct Equity Investment
- Open for Negotiation
Preferred Financing Model
- Equity
Type(s) of Last Financing Round of the project (if Applicable)
- Equity (private)
Main Service(s) Required
- Financial Services
Financial Services
- Institutional Investment
- Private Equity & Venture Capital
Attached files
Organisation
China (Hong Kong)
Similar opportunities
Project
Project for Potential Osteoarthritis Global Player
- No
- Yes
- Equity
- Bio-Tech
- Technology
- Bootstrapping
- Private Project
- Financial Services
- Open for negotiation
- Open for Negotiation
- 50,000,001 USD or above
- Direct Equity Investment
- 25,000,001 to 50,000,000 USD
- Private Equity & Venture Capital
- Investment / Financing Discussion
Seungtaek NA
CEO at StarryBio
South Korea
Project
通用型人类多能干细胞来源胰岛类器官糖尿病根治性疗法 (Off-the-shelf Stem Cell-derived Islet Organoid Therapy for Diabetes Cure)
- No
- Yes
- Equity
- Technology
- Equity (private)
- Financial Services
- Professional Services
- Minority Shareholdings
- Direct Equity Investment
- 25,000,001 to 50,000,000 USD
- 25,000,001 to 50,000,000 USD
- Investment / Financing Discussion
- Public-Private Partnership Project
Yi HE
CTO at 周易生物
China (Hong Kong)
Project
AI enabled Acceleration of Preclinical Biologic Drug Development
- No
- Yes
- Equity
- Bio-Tech
- Technology
- Private Project
- Equity (private)
- Financial Services
- Partner Identification
- Direct Equity Investment
- 10,000,001 to 25,000,000 USD
- Private Equity & Venture Capital
Kingsley Leung
Chairman & Co-founder at Great Bay Bio Limited
China (Hong Kong)